Literature DB >> 15018252

Clostridium difficile colitis associated with valaciclovir.

Susana De Andrés1, Daniel Ferreiro, Maribel Ibánez, Angel Ballesteros, Benito García, Jose Luis Agud.   

Abstract

OBJECTIVE: To report a case of Clostridium difficile colitis associated with valaciclovir treatment. CASE
SUMMARY: A 73-year-old man with lumbar herpes-zoster started valaciclovir 1 g tid. After three days he began vomiting and developed diarrhea, three to four stools per day. Symptoms worsened over the following days and he was admitted. Valaciclovir was stopped and fluid and electrolyte replacement was started. He continued 6 days later with diarrhea of 7 to 13 stools per day and a stool test for diagnosis of C. difficile infection was performed with a positive result. The patient received oral metronidazole (500 mg/t.i.d. for 10 days) and rapid improvement and eventual resolution of his diarrhea was observed after 3 days of therapy. DISCUSSION: Although no conclusive reports of this reaction exist, we think this is a case of C difficile colitis that appeared three days after valaciclovir was initiated. Colitis improved with metronidazole. Other causes of diarrhea were excluded, such as diabetes mellitus, renal failure, intestinal surgery and intestinal obstruction. Infection was confirmed by a positive test for C. difficile. The application of Naranjo's algorithm asserts the reaction as 'probable'.
CONCLUSIONS: Valaciclovir-associated C. difficile colitis, although rare, can have severe consequences for the patient's health. It should be included as a possible adverse effect of valaciclovir treatment by health professionals.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018252     DOI: 10.1023/b:phar.0000013481.72590.e3

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  10 in total

Review 1.  Clinical practice. Antibiotic-associated diarrhea.

Authors:  John G Bartlett
Journal:  N Engl J Med       Date:  2002-01-31       Impact factor: 91.245

2.  Diclofenac-induced pseudomembranous colitis.

Authors:  A Gentric; Y L Pennec
Journal:  Lancet       Date:  1992-07-11       Impact factor: 79.321

Review 3.  Drug-induced diarrhoea.

Authors:  O Chassany; A Michaux; J F Bergmann
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

4.  Clostridium difficile colitis following antiviral therapy in the acquired immunodeficiency syndrome.

Authors:  J Colarian
Journal:  Am J Med       Date:  1988-06       Impact factor: 4.965

5.  Acyclovir-associated colitis.

Authors:  M Moshkowitz; F M Konikoff; N Arber; M Baratz; T Gilat
Journal:  Am J Gastroenterol       Date:  1993-12       Impact factor: 10.864

Review 6.  Clostridium difficile--Associated diarrhea: A review.

Authors:  E Mylonakis; E T Ryan; S B Calderwood
Journal:  Arch Intern Med       Date:  2001-02-26

Review 7.  Management of protease inhibitor-associated diarrhea.

Authors:  D S Sherman; D N Fish
Journal:  Clin Infect Dis       Date:  2000-06-14       Impact factor: 9.079

Review 8.  Clostridium difficile.

Authors:  L Kyne; R J Farrell; C P Kelly
Journal:  Gastroenterol Clin North Am       Date:  2001-09       Impact factor: 3.806

Review 9.  Clostridium difficile infection associated with antineoplastic chemotherapy: a review.

Authors:  A Anand; A E Glatt
Journal:  Clin Infect Dis       Date:  1993-07       Impact factor: 9.079

10.  Phase I trial of valaciclovir, the L-valyl ester of acyclovir, in patients with advanced human immunodeficiency virus disease.

Authors:  M A Jacobson; J Gallant; L H Wang; D Coakley; S Weller; D Gary; L Squires; M L Smiley; M R Blum; J Feinberg
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

  10 in total
  1 in total

Review 1.  Clostridium difficile associated infection, diarrhea and colitis.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.